Diabetic Foot Clinical Trials
16 studies are recruiting for diabetic foot in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
By city
Studies now recruiting
-
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
This study is a platform study designed to efficiently test multiple biomarkers to identify diabetic foot ulcers (DFUs) with a higher potential for healing versus not healing that ultimately could be applied at the point of care to drive personalized management decisions, and to better inform clini…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Arizona College of Medicine, Tucson, Arizona
- Locations
- 9 in total
- Run by
- University of Michigan
-
Miro3D Wound Matrix for Treatment of Diabetic Foot Ulcers
This study is designed to evaluate whether the Miro3D Wound Matrix, when used in addition to standard of care, improves healing outcomes in patients with chronic diabetic foot ulcers. Diabetic foot ulcers are a common and serious complication of diabetes and may be difficult to heal despite appropr…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Advanced Foot Care, Phoenix, Arizona
- Locations
- 14 in total
- Run by
- Reprise Biomedical, Inc.
-
WIREDUP: Wearable Insoles for Recurrent Diabetic Ulcer Prevention
The primary aim of this study is to demonstrate the impact of the Orpyx® Sensory Insoles (Orpyx Medical Technologies Inc., Calgary AB, Canada) ("Orpyx" or "the Company") as an adjunct to the standard of care (SOC), as compared to SOC alone, on reducing plantar ulceration incidence in individuals wh…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Johns Hopkins Hospital, Baltimore, Maryland
- Run by
- Johns Hopkins University
-
Efficacy of a Topical Palmitated Formulation of Capsaicin (Capsadyn®) In the Treatment of Diabetic Neuropathic Foot Pain
The purpose of this research is to assess whether the use of a topical cream with an active ingredient can reduce the amount of foot pain experienced in participants who have been diagnosed with Diabetic Peripheral Neuropathy (DPN) with minimal side effects or discomfort from use.
- Stage
- EARLY_Phase 1
- Ages
- 25 to 75
- Site
- Carilion Clinic, Roanoke, Virginia
- Run by
- Carilion Clinic
-
Diabetic Foot Ulcer (DFU) Biofilm Infection and Recurrence
This work is based on DFU patients, seeks to conduct a fully powered clinical study testing i) If DFU with a history of biofilm infection closes with deficient barrier function. ii) whether such functionally deficient wound closure, manifested as high TEWL, is associated with greater wound recurren…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Arizona, Tucson, Arizona
- Locations
- 2 in total
- Run by
- University of Pittsburgh
-
Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs
The purpose of this study is to evaluate the efficacy of four dehydrated complete human placental membrane, also defined as Cellular, Acellular, Matrix-like Products/skin substitutes, plus SOC versus SOC alone in achieving complete closure of hard-to-heal diabetic foot ulcers over 12 weeks using a …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- SerenaGroup Omaha Research Center, Omaha, Nebraska
- Locations
- 5 in total
- Run by
- StimLabs
-
A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers
A multicenter, prospective, controlled clinical trial evaluating the efficacy of a single layer placental-based allograft and standard of care in the management of nonhealing diabetic foot ulcers.
- Stage
- Phase 4
- Ages
- 18 and older
- Site
- Royal Research, Hollywood, Florida
- Run by
- Applied Biologics, LLC
-
Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers
The purpose of this study is to evaluate the efficacy of human placental membrane products and standard of care versus standard of care alone in the management of nonhealing diabetic foot ulcers and venous leg ulcers.
- Stage
- Phase 4
- Ages
- 18 and older
- Site
- Center for Foot and Ankle Disorders, Philidelphia, Pennsylvania
- Run by
- BioLab Holdings
-
A Real-World Registry of Chronic Wounds and Ulcers
WOUNDJOURNEY is a longitudinal, real-world, observational registry designed to capture the full clinical course and patient journey associated with chronic wounds and ulcers. Data are collected during routine care from over 1,400 clinicians across the USA and Puerto Rico using a highly structured c…
- Stage
- Not phased
- Ages
- Any age
- Site
- US Wound Registry, The Woodlands, Texas
- Run by
- U.S. Wound Registry
-
Evaluating a Lifestyle Intervention to Prevent Recurrence of Diabetic Foot Ulcers
People with diabetes often experience foot ulcers, which can harm their ability to move, lower their quality of life, and increase the chances of losing a limb. These diabetic foot ulcers (DFUs) commonly come back (recur) even after they've healed, so it's crucial to stop them from returning to avo…
- Stage
- Not phased
- Ages
- 21 and older
- Site
- Keck Hospital of USC, Los Angeles, California
- Locations
- 3 in total
- Run by
- University of Southern California
-
Adapting Lifestyle Offloading for DFUs
The goal of this pilot clinical trial is to develop and test a tailored occupational therapist-led lifestyle-focused intervention to aid patients in improving diabetic foot ulcer care. The main questions it aims to answer are to determine the acceptability and feasibility of taking a tailored lifes…
- Stage
- Not phased
- Ages
- 21 and older
- Site
- University of Southern California, Los Angeles, California
- Run by
- University of Southern California
-
Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
Title A Multicenter, Prospective, Randomized Controlled Modified Multi-Platform (Matriarch) Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care versus Standard of Care alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
- Stage
- Phase 4
- Ages
- 21 and older
- Site
- Serena Group, Monroeville, Pennsylvania
- Run by
- Tiger Biosciences, LLC.
-
Dehydrated Human Amnion Membrane and Standard of Care Versus Standard of Care Alone in Nonhealing Diabetic Foot Ulcers
The purpose of this study is to evaluate the efficacy of dehydrated human amnion membrane (dhAM) and standard of care (SOC) versus SOC alone in the closure of nonhealing diabetic foot ulcers (DFUs).
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Performance Foot and Ankle Specialists, Thousand Oaks, California
- Run by
- Axolotl Biologix
-
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
The purpose of the study is to evaluate the efficacy of multiple human placental membrane products and Standard of Care (SOC) versus SOC alone in the management of nonhealing diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs) over 12 weeks using a modified platform trial design.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Poirot Podiatry, Metairie, Louisiana
- Run by
- C5 Biomedical
-
Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of Care
A Randomized Controlled Multicenter Clinical Trial, Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care versus Standard of Care alone in the management of Nonhealing Diabetic Foot Ulcers
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Detroit Foot and Ankle, Clinton Township, Michigan
- Run by
- Applied Biologics, LLC
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
This study will evaluate two human amnion/chorion membrane (ppLHACM) products and Standard of Care (SOC) versus SOC alone in the closure of nonhealing diabetic foot ulcers (DFUs).
- Stage
- Not phased
- Ages
- 18 and older
- Site
- SerenaGroup - Monroeville, Monroeville, Pennsylvania
- Run by
- MiMedx Group, Inc.
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.